Fas ligand upregulation is an early event in colonic carcinogenesis.
about
Inactivation of the transcription factor GLI1 accelerates pancreatic cancer progression.Human FasL gene is a target of β-catenin/T-cell factor pathway and complex FasL haplotypes alter promoter functions.Regulation of caspase-6 and FLIP by the AMPK family member ARK5.A common hereditary single-nucleotide polymorphism in the gene of FAS and colorectal cancer survival.Expression of Fas ligand and caspase-3 contributes to formation of immune escape in gastric cancer.Newly established tumourigenic primary human colon cancer cell lines are sensitive to TRAIL-induced apoptosis in vitro and in vivo.Fas ligand mediates immune privilege and not inflammation in human colon cancer, irrespective of TGF-beta expression.The clinical significance of autoantibodies in gastrointestinal malignancies: an overview.Prostaglandin E2 stimulates Fas ligand expression via the EP1 receptor in colon cancer cells.Human and mouse colon cancer utilizes CD95 signaling for local growth and metastatic spread to liver.Fas ligand expression in lynch syndrome-associated colorectal tumours.Requirement of inositol 1,4,5-trisphosphate receptors for tumor-mediated lymphocyte apoptosis.Molecular mechanism of anticancer effect of Sclerotium rolfsii lectin in HT29 cells involves differential expression of genes associated with multiple signaling pathways: A microarray analysis.Topics in histopathology of sweat gland and sebaceous neoplasms.Role of cytokines in promoting immune escape of FasL-expressing human colon cancer cells.The Fas-FasL system and colorectal tumours.Expression of apoptosis regulating proteins identifies stage II and III colon cancer patients with high risk of recurrence.Progesterone-induced apoptosis in immortalized normal and malignant human ovarian surface epithelial cells involves enhanced expression of FasL.c-FLIP expression in colorectal carcinomas: association with Fas/FasL expression and prognostic implications.Apoptosis-Mediated Chemoprevention by Different Ratios of Fish Oil in Experimental Colon Carcinogenesis.
P2860
Q33718581-84A9A589-D776-4946-82F2-87EFDF477B3BQ34056050-99188030-B877-4516-8796-B8E7367D933EQ34335776-65A02B53-A821-4B7E-B4E5-8B6B5774C884Q35893369-07EC3A27-F464-4C58-8359-6DE9DAC189B7Q36190611-AEB8F686-8738-4668-AA60-74606E918C5CQ36608654-FE20D154-36DC-4FEA-ACDE-3D45DB7AEA90Q36671108-1A70F388-9B65-44ED-B2EA-05401F9CB795Q36764924-11EACC78-B200-4EBF-8C28-94CF9AFA693EQ36858103-C1876E82-43DC-4608-A548-2D4FAFA122E8Q37391035-DCCD8640-3A25-4B28-9A0E-6AB12B52E922Q37469193-99FF01B9-7CD4-4D51-827E-42FCB7CE4171Q38291229-DAAB6D5B-03F7-4AAF-ACE9-B29CD687EF8EQ38837139-BF943C86-BAAA-4D2B-A664-CE75EC6BB299Q39159820-8340D81C-B235-43D0-91C5-9998B4421B2FQ40403108-B76BDCC7-48E6-427A-BACE-49BEE2332FCAQ43011499-0A949607-A8C3-47EC-8E82-FB8E69C6566CQ43692641-382D92F1-16F4-4522-9B9C-BFA0DC7343B3Q44611177-70434FD2-2EDF-4140-A82C-4CF5E7FD2AE0Q52579698-4F3C9B23-AD1F-411A-B404-74F4AE5E4DBBQ53098952-0E4E17F6-9091-48A0-B54A-5D30790A38A2
P2860
Fas ligand upregulation is an early event in colonic carcinogenesis.
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Fas ligand upregulation is an early event in colonic carcinogenesis.
@ast
Fas ligand upregulation is an early event in colonic carcinogenesis.
@en
type
label
Fas ligand upregulation is an early event in colonic carcinogenesis.
@ast
Fas ligand upregulation is an early event in colonic carcinogenesis.
@en
prefLabel
Fas ligand upregulation is an early event in colonic carcinogenesis.
@ast
Fas ligand upregulation is an early event in colonic carcinogenesis.
@en
P2093
P2860
P356
P1476
Fas ligand upregulation is an early event in colonic carcinogenesis.
@en
P2093
Bennett MW
Collins JK
O'Connell J
O'Sullivan GC
Shanahan F
P2860
P304
P356
10.1136/JCP.54.8.598
P407
P577
2001-08-01T00:00:00Z